drugset / Trial / NCT00447473
Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
This trial represents an attempt to offer second line immunotherapy plus chemotherapy to patients who have failed prior taxane base therapy.
Timeline
- Start
- 2006-07
- Primary completion
- 2008-08
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketoconazole | Small molecule | 400 mg | Oral |
| Subject | Mitoxantrone | Small molecule | 12 mg/m2 | — |
| Subject | sargramostim | Protein / enzyme biologic | 250 ug/m2 | Subcutaneous |